ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LNTH Lantheus Holdings Inc

65.21
0.80 (1.24%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 584,986
Bid Price 62.39
Ask Price 65.84
News -
Day High 65.37

Low
50.20

52 Week Range

High
100.48

Day Low 63.61
Company Name Stock Ticker Symbol Market Type
Lantheus Holdings Inc LNTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.80 1.24% 65.21 17:30:00
Open Price Low Price High Price Close Price Prev Close
64.62 63.61 65.37 65.21 64.41
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,233 584,986 $ 64.50 $ 37,730,731 - 50.20 - 100.48
Last Trade Time Type Quantity Stock Price Currency
17:55:50 4 $ 65.83 USD

Lantheus (LNTH) Options Flow Summary

Overall Flow

Bullish

Net Premium

28k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Lantheus Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.47B 68.53M - 1.3B 326.66M 4.77 13.67
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lantheus News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LNTH Message Board. Create One! See More Posts on LNTH Message Board See More Message Board Posts

Historical LNTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week61.9765.5461.4662.96770,2103.245.23%
1 Month59.4165.5458.3161.20696,5725.809.76%
3 Months53.4869.7351.7960.31857,69911.7321.93%
6 Months67.7079.2050.2061.141,102,951-2.49-3.68%
1 Year90.65100.4850.2069.921,081,573-25.44-28.06%
3 Years22.28100.4819.30160.79982,19242.93192.68%
5 Years24.77100.488.6750.12772,96240.44163.26%

Lantheus Description

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

Your Recent History

Delayed Upgrade Clock